These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 37375758)

  • 1. Local Delivery Strategies for Peptides and Proteins into the CNS: Status Quo, Challenges, and Future Perspectives.
    Yue W; Shen J
    Pharmaceuticals (Basel); 2023 May; 16(6):. PubMed ID: 37375758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatment of CNS Disorders: Challenges and Possibilities.
    Sa P; Singh P; Dilnawaz F; Sahoo SK
    Curr Pharm Des; 2022; 28(33):2742-2757. PubMed ID: 35909283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.
    Xie J; Shen Z; Anraku Y; Kataoka K; Chen X
    Biomaterials; 2019 Dec; 224():119491. PubMed ID: 31546096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System.
    Pandey M; Jain N; Kanoujia J; Hussain Z; Gorain B
    Front Pharmacol; 2022; 13():865590. PubMed ID: 35401164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.
    Zhou X; Smith QR; Liu X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1695. PubMed ID: 33470550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.
    Banks WA
    Nat Rev Drug Discov; 2016 Apr; 15(4):275-92. PubMed ID: 26794270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
    Kanazawa T
    Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.
    Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK
    J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
    Zhao X; Ye Y; Ge S; Sun P; Yu P
    Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Ligands Deliver Model Drug Cargo into the Central Nervous System along Autonomic Neurons.
    Sellers DL; Tan JY; Pineda JMB; Peeler DJ; Porubsky VL; Olden BR; Salipante SJ; Pun SH
    ACS Nano; 2019 Oct; 13(10):10961-10971. PubMed ID: 31589023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agile delivery of protein therapeutics to CNS.
    Yi X; Manickam DS; Brynskikh A; Kabanov AV
    J Control Release; 2014 Sep; 190():637-63. PubMed ID: 24956489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNS drug delivery: opioid peptides and the blood-brain barrier.
    Witt KA; Davis TP
    AAPS J; 2006 Feb; 8(1):E76-88. PubMed ID: 16584136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendrimer advances for the central nervous system delivery of therapeutics.
    Xu L; Zhang H; Wu Y
    ACS Chem Neurosci; 2014 Jan; 5(1):2-13. PubMed ID: 24274162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobiotechnology-based drug delivery to the central nervous system.
    Jain KK
    Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology for CNS delivery of bio-therapeutic agents.
    Shah L; Yadav S; Amiji M
    Drug Deliv Transl Res; 2013 Aug; 3(4):336-51. PubMed ID: 23894728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics.
    Akhtar A; Andleeb A; Waris TS; Bazzar M; Moradi AR; Awan NR; Yar M
    J Control Release; 2021 Feb; 330():1152-1167. PubMed ID: 33197487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for transporting nanoparticles across the blood-brain barrier.
    Zhang TT; Li W; Meng G; Wang P; Liao W
    Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleic acid therapies for CNS diseases: Pathophysiology, targets, barriers, and delivery strategies.
    Padmakumar S; D'Souza A; Parayath NN; Bleier BS; Amiji MM
    J Control Release; 2022 Dec; 352():121-145. PubMed ID: 36252748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.